In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trends In Diagnostics – 2012

Executive Summary

Diagnostics industry trends include the increasing adoption of genomics in clinical testing and with it a focus on services and workflow more so than differentiated technology; a slowdown in M&A activity, partly to allow the digestion of assets acquired in 2010-11; and the ongoing uncertainties of regulation and reimbursement of high-value molecular tests.

Advertisement

Related Content

2013: The Year In Diagnostics
Molecular Diagnostics M&A: Dormant But Not Done
The Balkanized State Of Molecular Diagnostics Reimbursement
Genomics Enters The Neonatal ICU
Hologic Grabs Gen-Probe
Roche Pounces On Market-Weakened Illumina
Trends In Diagnostics 2011
What's Fueling The Recent Diagnostics Dealmaking?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003936

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel